| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |